Black patients were less likely to receive PARP inhibitors, despite having BRCA1/2 testing and positivity rates comparable to White patients, and were at higher risk of death.

Ads for ‘misleading’ prostate supplements and home testing kits banned - The Advertising Standards Authority said misleading ...

Building distributed apps requires specialized tools. Microsoft delivers with an API simulator that supports complex mocks ...

The US FCC is considering barring China Mobile, China Telecom, and China Unicom from US networks due to concerns over their ...

With the intent to promote vaccination over routine testing for unvaccinated individuals, the Pima County Health Department has changed its criteria for free COVID-19 testing. Those presenting ...

Objectives Bedaquiline (BDQ), delamanid (DLM) and pretomanid (Pa) were widely used in recent years. This study aimed to analyse adverse drug event (ADE) reports associated with them based on the Food ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

A new study from Cedars-Sinai Cancer brings hopeful news about liver cancer in the United States. Researchers found that the ...

CNET staff -- not advertisers, partners or business interests -- determine how we review products and services. If you buy through our links, we may earn a commission.

To advance its health legislative framework, enhance patient safety, and ensure alignment with the nation’s objectives for modernising healthcare legislation ...